Femasys Inc.

FEMY | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.56

+$0.03 (+1.19%)

At close: Sep 22, 2026, 4:00 PM ET

$2.61

+$0.05 (+1.95%)

After-hours: Sep 22, 2026, 7:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.19%

(1D)

Rating

Updated: Sep 12, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $7.73M

1D Range

2.55 2.69

52W Range

2.02 22.20

Valuation (TTM)

PE -0.57

PB 1.90

EV/EBITDA -1.08

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target $10

Cash Flow

FCF Yield -237.2%

SBC Adj. FCF Yield -245.1%

SBC Impact -3.3%

Margins

Gross Margin 52.2%

Operating Margin -763.9%

FCF Margin -788.0%

Growth (CAGR)

Revenue 3Y | 5Y 24.3% | 13.0%

Dil EPS 3Y | 5Y 48.7% | 18.4%

FCF 3Y | 5Y -8.3% | -17.4%

Returns

ROA -100.0%

ROE -226.0%

ROIC -197.9%

Financial Health

Net Debt

$3.35M

Current Ratio 2.14

Interest Coverage -13.48

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line inclu...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 53

IPO Date Jun 17, 2021

Website www.femasys.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 17, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$10

Upside

+290.63%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞